Rex Bionics
Rex Bionics widens full-year loss as commercialisation costs rise
Rex Bionics Plc, the New Zealand company listed on the London Stock Exchange's AIM market, said higher costs to commercialise its robotic exoskeletons.
By Pattrick Smellie
•
3 min read
•
Wed, 4th Mar 2015